Citigroup reiterated coverage on Owlet with a new price target
$OWLT
Industrial Machinery/Components
Industrials
Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/23/2025 | $7.00 | Outperform | Northland Capital |
| 10/6/2021 | $12.00 → $5.00 | Neutral | Citigroup |
| 10/5/2021 | $8.50 → $5.50 | Buy → Neutral | BofA Securities |
| 9/8/2021 | $8.50 | Buy | BofA Securities |
| 8/5/2021 | $11.00 | Neutral | Citigroup |
Northland Capital initiated coverage of Owlet with a rating of Outperform and set a new price target of $7.00
Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously
BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously
S-3 - Owlet, Inc. (0001816708) (Filer)
S-8 - Owlet, Inc. (0001816708) (Filer)
10-Q - Owlet, Inc. (0001816708) (Filer)
This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet's data through Locus Health's platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in remote patient monitoring, for more integrated infant health management. The collaboration connects data from Owlet's FDA-cleared prescription device, BabySat®, directly into the Locus Health platform, giving healthcare providers ongoing and secure access to vital infant health information after hospital disch
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of
Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Rhapsody, a global leader in digital health enablement and interoperability, to securely connect infant health insights from Owlet's FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electronic health record (EHR) workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112744527/en/Owlet partners with Rhapsody to securely connect infant vital signs from
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
4 - Owlet, Inc. (0001816708) (Issuer)
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 646-844-6383 (international) and reference Access Code 428622. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay w
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m
Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome
Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'
SC 13G/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)
SC 13D/A - Owlet, Inc. (0001816708) (Subject)